Not Yet RecruitingNot Applicable

Exploring the Effectiveness of Digital Anti-stigma Therapy on Illness Perception and Perceived Stigma in Patients With Schizophrenia and Their Primary Caregivers

Taiwan360 participantsStarted 2024-10

Plain-language summary

This study aims to investigate the relationship between illness insight, self-stigma in patients with schizophrenia, and the awareness and associated stigma experienced by their families, as well as the predictors of these factors. The study will use information technology strategies for educational purposes, specifically employing 3D glasses for delivering this education. The goal is to develop a disease adaptation program that involves both patients and their families, helping to enhance disease awareness and improve stigma experiences.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥ 18 years;
✓. Patients who meet the DSM-5 criteria for schizophrenia or the ICD-10 diagnosis code F20, including those who are expected to be discharged from a psychiatric ward within two weeks or are outpatients;
✓. Have family members involved in caregiving (i.e., relatives who assist with daily needs, supervise medication, help with medical visits, and maintain contact with hospital staff during hospitalization, including non-blood-related cohabitants);
✓. Are literate, able to independently read and complete questionnaires, can operate basic tablet or smartphone functions after instruction, and are willing to participate in this study.
✓. Age ≥ 18 years;
✓. Family members providing care for psychiatric outpatients or inpatients diagnosed with schizophrenia (i.e., relatives who assist with daily needs, supervise medication, help with medical visits, and maintain contact with hospital staff during hospitalization, including non-blood-related cohabitants);
✓. Literate, able to independently read and complete questionnaires, can operate basic tablet or smartphone functions after instruction, and are willing to participate.

Exclusion criteria

What they're measuring

Positive and Negative Syndrome Scale

Timeframe: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.

The Schedule for the Assessment of Insight

Timeframe: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.

Internalized Stigma of Mental Illness

Timeframe: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.

Medication Adherence Rating Scale

Timeframe: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.

Drug Attitude Inventory-10

Timeframe: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.

Illness Perception Questionnaire-Revised Version for Families of Patients with Schizophrenia

Timeframe: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.

Trial details

NCT IDNCT06563752

SponsorNational Yang Ming Chiao Tung University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12

Contact for this trial

Chiu-Yueh Yang, PhD

+8860228267388 Cyyang530904@nycu.edu.tw

View on ClinicalTrials.gov More Schizophrenia trials

Plain-language summary

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥ 18 years;
✓. Patients who meet the DSM-5 criteria for schizophrenia or the ICD-10 diagnosis code F20, including those who are expected to be discharged from a psychiatric ward within two weeks or are outpatients;
✓. Have family members involved in caregiving (i.e., relatives who assist with daily needs, supervise medication, help with medical visits, and maintain contact with hospital staff during hospitalization, including non-blood-related cohabitants);
✓. Are literate, able to independently read and complete questionnaires, can operate basic tablet or smartphone functions after instruction, and are willing to participate in this study.
✓. Age ≥ 18 years;
✓. Family members providing care for psychiatric outpatients or inpatients diagnosed with schizophrenia (i.e., relatives who assist with daily needs, supervise medication, help with medical visits, and maintain contact with hospital staff during hospitalization, including non-blood-related cohabitants);
✓. Literate, able to independently read and complete questionnaires, can operate basic tablet or smartphone functions after instruction, and are willing to participate.

Exclusion criteria

What they're measuring

Positive and Negative Syndrome Scale

Timeframe: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.

The Schedule for the Assessment of Insight

Timeframe: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.

Internalized Stigma of Mental Illness

Timeframe: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.

Medication Adherence Rating Scale

Timeframe: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.

Drug Attitude Inventory-10

Timeframe: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.

Illness Perception Questionnaire-Revised Version for Families of Patients with Schizophrenia

Timeframe: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.